Therapeutic Workshop
Hepatitis C Might Earn An “A"
Wednesday, October 19
9:10 a.m. - 10:10 a.m.
Twin Peaks South
Experts and clinicians will discuss new chemical entities and approaches to treating Hepatitis C. Topics covered included combination regimens that are currently in the clinic and that have the potential to change the paradigm for Hepatitis C therapy.
Moderator:
- David Witzke, PhD, Principal, Senior Research Analyst, Bank of America Securities LLC
Panelists:
- Milind Deshpande, PhD, Senior Vice President, Drug Discovery, Achillion Pharmaceuticals, Inc.
- Arthur M. Krieg, MD, Chief Scientific Officer, Senior Vice President Research and Development, and Co-Founder, Coley Pharmaceutical Group
- Karling Alice Leung, MBA, President and CEO, Intarcia Therapeutics, Inc.
- Jean-Pierre Sommadossi, PhD, PharmD, Founder, Chief Executive Officer and Chairman, Idenix Pharmaceuticals, Inc.
- Kevin Steffy, PhD, Virology / Cell Biology Group Leader, Anadys Pharmaceuticals, Inc.